Orlando, FL (PRWEB) September 25, 2012
Actos Bladder Cancer Association Protects and Informs Injured Patients and Families
Actosbladdercancer.as distinguishes itself as an outstanding source of information for consumers worldwide
With more than 10,000 lawsuits anticipated as a result of the link between the type 2 diabetes drug Actos and bladder cancer, the nationally recognized Actos Bladder Cancer Association launched a new consumer-based website to inform and protect injured patients and their families.
Actosbladdercancer.as is the one-stop choice for information about Actos, Actosplus met, Actosplus met XR, Duetact and their links to bladder cancer. The site not only offers comprehensive information about the medication, but it also includes exhaustive details about the drug’s link to bladder cancer. Actosbladdercancer.as provides the most news about medical advances in bladder cancer treatment options and bladder-cancer clinical trials. It is also aimed at helping weary and worried Actos patients get through their stress of this devastating diagnosis and understand the intricacies of a variety of legal options.
Actos, which has a generic name of pioglitazone, was released to the market in 1999. Quickly, researchers found the drug’s link to bladder cancer, congestive heart failure, edema and a variety of other potentially dangerous side effects, as stated on the drug’s labeling. In recent years, study after study has shown the drug’s increasing link to bladder cancer; the most recent published in the British Medical Journal (BMJ) points to an more than 80 percent increased risk of bladder cancer in those taking the drug for longer than two years or those taking higher doses. BMJ researchers think that the drug causes crystals to form in the urinary bladder. These crystals irritate the hollow muscular organ, change the makeup of the cells and cause cancer, researchers said.
At the same time, drug regulators in France, Germany and Canada have removed Actos from pharmacy shelves or severely limited consumer access to the drug. In the United States, the Food and Drug Administration (FDA) has only tweaked the wording on the drug’s label to include information about the increased risk of bladder cancer. Actos also carries a black-box warning, the FDA’s strongest caution, regarding the drug’s link to congestive heart failure. The drug is known to cause heart failure in patients both with and without pre-existing heart conditions, according to an FDA safety communication. The FDA also said Actos is linked to liver problems, edema, weight gain, macular edema and random broken bones.
While there has yet to be an Actos recall in the U.S., patients and physicians remain very concerned. Many physicians have been steering their patients toward more tried-and-true medications for type 2 diabetes control, including metformin. At the same time, consumer-advocacy groups are pushing for the drug to be recalled before more innocent patients are injured or die.
Already, thousands of injured patients and their families have filed lawsuits in federal and state courts nationwide, court records show (Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette). Many injured patients said they feel duped by Takeda Pharmaceuticals and its subsidiaries for selling a drug with known risks. Bloomberg News reported that Actos litigation could reach up to 10,000 lawsuits. In addition to the patient concerns, a federal whistleblower lawsuit claims that Takeda executives knew about the drug’s cancer, heart failure and other risks and worked to hide them from drug regulators, court records show (U.S. ex rel. Helen Ge v. Takeda Pharmaceutical Co., 10-cv-11043, U.S. District Court, District of Massachusetts (Boston).
The Actos Bladder Cancer Association can help those who are suffering from the life-changing side effects from Actos. Actosbladdercancer.as offers patients an opportunity to learn about the drug and how it works in the body. We also offer around-the-clock support for patients or family members who are confused and don’t know where to turn for advice. There are numerous ways Actobladdercancer.as can help:
Support book — Our “100 Questions and Answers about Bladder Cancer” support book is an encouraging and informative look at the disease. This patient-focused guide offers practical answers to the most asked questions about this disease, including information about the most current treatment options and coping strategies. Most importantly, it’s written in plain English without medical jargon or lingo.
Support wristbands — For patients, family members, friends and health-care professionals, these wristbands are a wonderful way to show support and love. They are a physical reminder of the struggle and successes that can happen in the fight against bladder cancer. We will send you two for free.
Clinical trials — Our staff of dedicated professionals are constantly scouring the newest information about Actos, bladder-cancer research and clinical trials. Our goal is to ensure that patients have as much information as they want. We also continuously update the most current clinical-trial resources to ensure that patients who want to participate in one have immediate access to the information they need to get started.
Emotional support — We have a staff of patient and family advocates who are versed in the complexities of actos bladder cancer. They help patients sort out what information is pertinent to their medical diagnosis and help family members who feel scared and confused. They answer questions at no cost.
Legal advice — As everyone knows, a serious medical diagnosis, especially a bladder-cancer diagnosis, can cripple a family’s budget. It is important to have the best attorneys on your side. We offer free legal advice from one of the highest-rated firms in the country. You pay nothing unless we make a recovery on your behalf.
For more information about the Actos Bladder Cancer Association and Actosbladdercancer.as, or to speak with one of our patient advocates, please call (800) 574-7976 or email us at email@example.com.